Enzyme-activating antibodies revealed as marker for most severe form of rheumatoid arthritis
In a series of lab experiments designed to unravel the workings of a key enzyme widely considered a possible trigger of rheumatoid arthritis, researchers at Johns Hopkins have found that in the most severe ...
Arthritis & Rheumatism
May 22, 2013 |
5 / 5 (3) |
0
|
Genetic variation among patients with pulmonary fibrosis associated with improved survival
Variation in the gene MUC5B among patients with idiopathic pulmonary fibrosis was associated with improved survival, according to a study published online by JAMA. The study is being released early online to coincide with i ...
Diseases, Conditions, Syndromes
May 21, 2013 |
not rated yet |
0
Leading researchers report on the elusive search for biomarkers in Huntington's disease
While Huntington's disease (HD) is currently incurable, the HD research community anticipates that new disease-modifying therapies in development may slow or minimize disease progression. The success of HD research depends ...
Neuroscience
May 20, 2013 |
5 / 5 (1) |
0
Scientists develop drug that slows Alzheimer's in mice
A drug developed by scientists at the Salk Institute for Biological Studies, known as J147, reverses memory deficits and slows Alzheimer's disease in aged mice following short-term treatment. The findings, ...
Alzheimer's disease & dementia
May 13, 2013 |
4.2 / 5 (5) |
0
|
Treatment with A1-PI slows the progression of emphysema in Alpha-1 antitrypsin deficiency
Treatment with an Alpha-1 proteinase inhibitor (A1-PI), a naturally occurring protein that protects lung tissue from breakdown and protects the lung's elasticity, is effective in slowing the progression of emphysema in patients ...
Cancer
May 21, 2013 |
not rated yet |
0
Scientists identify early predictors of disease progression which could speed Huntington's disease drug trials
Scientists have identified a set of tests that could help identify whether and how Huntington's disease (HD) is progressing in groups of people who are not yet showing symptoms. The latest findings from the TRACK-HD study, ...
Neuroscience
May 08, 2013 |
not rated yet |
0
Ambrisentan not effective in idiopathic pulmonary fibrosis
(HealthDay)—The endothelin A receptor-selective antagonist ambrisentan is not effective for reducing the rate of idiopathic pulmonary fibrosis (IPF) progression, according to a study published in the May ...
Diseases, Conditions, Syndromes
May 07, 2013 |
not rated yet |
0
Scientists much closer to developing screening test for early detection of Alzheimer's disease
They identified blood-based biological markers that are associated with the build up of a toxic protein in the brain which occurs years before symptoms appear and irreversible brain damage has occurred.
Alzheimer's disease & dementia
May 01, 2013 |
not rated yet |
0
Cell response to new coronavirus unveils possible paths to treatments
NIH-supported scientists used lab-grown human lung cells to study the cells' response to infection by a novel human coronavirus (called nCoV) and compiled information about which genes are significantly disrupted ...
Diseases, Conditions, Syndromes
Apr 30, 2013 |
5 / 5 (1) |
0
Team finds melatonin delays ALS symptom onset and death in mice
Melatonin injections delayed symptom onset and reduced mortality in a mouse model of the neurodegenerative condition amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, according to a new study by researchers at ...
Neuroscience
Apr 25, 2013 |
not rated yet |
0
